Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Growth Strength And Positive Analyst Sentiment

Catalyst Pharmaceuticals (CPRX) has come onto investors’ radar after appearing on an “Affordable Growth” screen. The screen highlights a mix of double-digit earnings and revenue growth, solid profitability and a debt-free balance sheet. See our latest analysis for Catalyst Pharmaceuticals. At a share price of US$24.30, Catalyst Pharmaceuticals has seen a 14.25% 90 day share price return. The 1 year total shareholder return of 7.71% and very large 5 year total shareholder return suggest...
NYSE:FLR
NYSE:FLRConstruction

Is Fluor (FLR) Pricing Look Compelling After Recent Mixed Share Performance

If you are wondering whether Fluor's current share price lines up with its underlying value, this breakdown will help you make sense of what the market is really pricing in today. Fluor's shares last closed at US$46.19, with returns of 1.3% over the past week, 16.6% over the past month, 10.8% year to date and a 4.2% decline over the last year, alongside returns of 27.4% over three years and 138.6% over five years. These mixed return figures have kept Fluor on many investors' watchlists, as...
TSE:4519
TSE:4519Pharmaceuticals

Chugai Pharmaceutical (TSE:4519) Earnings Growth And 34.5% Margin Test Premium Valuation Narrative

Chugai Pharmaceutical (TSE:4519) has wrapped up FY 2025 with fourth quarter revenue of ¥346.3 billion and basic EPS of ¥78.03, rounding out a year in which trailing twelve month revenue came in at ¥1.26 trillion and EPS reached ¥263.73. Over the past few quarters, the company has seen revenue move from ¥288.5 billion and EPS of ¥59.09 in Q1 2025 to ¥346.3 billion and EPS of ¥78.03 in Q4, while trailing twelve month revenue and EPS have shifted from ¥1.17 trillion and ¥235.39 a year earlier to...
WBAG:LNZ
WBAG:LNZChemicals

Lenzing (WBAG:LNZ) Valuation Check After Long Term Energie AG Deal And Decarbonization Push

Lenzing (WBAG:LNZ) is back in focus after extending its cooperation with Energie AG Umwelt Service at the Reststoffverwertung Lenzing residual material facility, securing operations through 2040 and reinforcing long term energy and climate planning. See our latest analysis for Lenzing. The latest framework agreement lands at a time when Lenzing’s share price has a 30 day share price return of 8.97% and a year to date share price return of 6.47%. However, the 5 year total shareholder return of...
NYSE:AS
NYSE:ASLuxury

How Investors May Respond To Amer Sports (AS) Early Partial Redemption Of 6.750% Senior Notes

Amer Sports, Inc. recently announced it will redeem US$80,000,000 of its 6.750% Senior Secured Notes due 2031 on February 6, 2026, at 103.000% of principal plus accrued interest. This partial early redemption, alongside the scheduled February 24, 2026 release of fourth quarter and fiscal 2025 results, highlights management’s current focus on balance sheet structure and financial communication. Next, we’ll examine how this early debt redemption shapes Amer Sports’ investment narrative and...
TSE:6366
TSE:6366Construction

Is It Too Late To Consider Chiyoda (TSE:6366) After A 323% One Year Surge?

If you are wondering whether Chiyoda shares still offer value after a strong run, this article walks through what the current price might be implying about the business. Chiyoda's share price, which last closed at ¥1,282, comes with sizeable reported returns of 43.4% over 7 days, 74.4% over 30 days, 53.7% year to date and 323.1% over 1 year. These moves sit alongside ongoing investor interest in the capital goods space and renewed attention on companies listed on the Tokyo Stock Exchange...
NYSE:ITW
NYSE:ITWMachinery

How Investors May Respond To Illinois Tool Works (ITW) EPS Outlook, Insider Buying and Trimmed Estimates

In recent commentary, analysts projected year-over-year earnings-per-share growth for Illinois Tool Works across key segments such as Automotive OEM, Food Equipment, Welding, and Specialty Products, even as consensus estimates were trimmed slightly over the last month. Over the past five years, the company’s earnings-per-share growth outpaced its share price gains, with dividends and recent insider share purchases adding an extra layer of interest for investors. Next, we’ll examine how...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Assessing Critical Metals (CRML) Valuation After A Sharp Weekly Pullback And Premium 15x P/B Multiple

Event overview and immediate context Critical Metals (CRML) has attracted fresh attention after a sharp 36.1% decline over the past week, following a strong month in which the stock returned 89.8%. This has prompted investors to reassess recent price moves. See our latest analysis for Critical Metals. Set against a year to date share price return of 62.2% and a 1 year total shareholder return of 70.6%, the recent weekly pullback suggests some of the earlier momentum may be cooling for now. If...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Why Sandisk (SNDK) Is Up 21.6% After AI-Driven Beat And Extended Kioxia Capacity Pact

In late January 2026, Sandisk reported past second-quarter results showing sharply higher sales and profits and issued upbeat third-quarter revenue guidance, citing intense AI-driven demand for its NAND flash and enterprise SSD products. On the same day, Kioxia Corporation and Sandisk announced they had extended their long-running Yokkaichi and Kitakami flash-memory joint venture agreements through 2034, with Sandisk committing US$1.17 billion in staged payments to secure long-term...
NasdaqGS:OZK
NasdaqGS:OZKBanks

How Investors May Respond To Bank OZK (OZK) After Boston CRE Write-Off Amid Higher Interest Income

In January 2026, Bank OZK reported fourth-quarter 2025 results showing higher net interest income of US$407.05 million but slightly lower net income of US$175.96 million, alongside a US$72 million write-off on a vacant East Cambridge commercial property. This write-off underscores Bank OZK’s meaningful exposure to commercial real estate, particularly in the Boston market, where it has about US$1.40 billion in active loans. With recent results highlighting the US$72 million commercial real...
TSE:6501
TSE:6501Industrials

Hitachi (TSE:6501) Margin Improvement Reinforces Bullish Earnings Narrative Despite Premium P/E

Hitachi Q3 2026 earnings snapshot Hitachi (TSE:6501) has reported new figures for Q3 2026, posting revenue of ¥2,714.4b and basic EPS of ¥36.64, with trailing twelve month EPS at ¥180.73. The company’s revenue increased from ¥2,465.2b in Q3 2025 to ¥2,714.4b in Q3 2026. Over the same period, basic EPS rose from ¥30.20 to ¥36.64, alongside trailing twelve month net income of ¥823.50b. With a trailing net margin of 8%, the latest figures give investors a clearer view of current...
NasdaqGS:INMD
NasdaqGS:INMDMedical Equipment

Is InMode (INMD) Priced Attractive After Recent 7% Monthly Share Price Gain

Wondering if InMode at around US$15.71 is a bargain or a value trap? This article will walk you through what the current price might be implying. The stock has returned 12.6% over the last 7 days and 6.9% over the last 30 days, although the 1 year return of 8.7% and 3 year return of 57.8% show a very different experience for longer term holders. That mix of shorter term gains and weaker multi year returns has kept attention on how the market is reassessing InMode, with many investors...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Assessing Natera (NTRA) Valuation After Recent Share Price Gains And Strong Long Term Returns

Natera stock snapshot after recent moves Natera (NTRA) has seen mixed returns recently, with a 0.1% gain over the past month and a 16.2% rise over the past 3 months, leaving shares around $231.14 at the last close. See our latest analysis for Natera. In the short term, Natera’s share price has eased back, with a 7-day share price return showing a 4.3% decline. However, the 90-day share price return of 16.2% and a 3-year total shareholder return above 4x indicate that momentum has been strong...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Is Advanced Energy Industries (AEIS) Still Reasonably Valued After Its 122% One Year Surge

If you are wondering whether Advanced Energy Industries is still fairly priced after its strong run, this article will walk through what the current numbers actually say about value. The stock last closed at US$255.36, with returns of 22.0% over the past 30 days and 122.5% over the past year, following gains of 15.0% year to date, 160.3% over 3 years and 130.1% over 5 years. Recent news coverage has focused on Advanced Energy Industries as part of broader discussions about semiconductor...
TSE:7182
TSE:7182Banks

Is JAPAN POST BANK (TSE:7182) Recasting Its Fee Model With a Unified Asset Management Platform?

Japan Post Bank Co., Ltd. recently held a board meeting to consider creating Japan Post Bank Asset Management Co., Ltd. via an absorption-type merger with Japan Post Co., Ltd., integrating JP Asset Management and Japan Post Investment into a single platform. This planned integration of retail investment trusts and private equity reflects Japan Post Bank’s effort to deepen client relationships and enhance fee-based income within Japan’s push to build a stronger asset management hub. We’ll now...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

Assessing Sezzle (SEZL) Valuation After CFO Transition To Lee Brading

Sezzle (SEZL) just announced a finance leadership change, with longtime Chief Financial Officer Karen Hartje retiring and Lee Brading stepping into the CFO role, a shift that immediately puts the stock under closer investor scrutiny. See our latest analysis for Sezzle. The CFO transition comes as Sezzle’s recent share price return has softened, with a 1 day move of 10.31% lower and a 7 day share price return of 6.45% lower, even though the 1 year total shareholder return sits at 62.15%. This...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

How Investors May Respond To Alvotech (ALVO) Securing Global Rights For Its Eylea Biosimilar Launch

Alvotech recently announced it had finalized a global licensing and settlement agreement with Regeneron and Bayer, resolving past worldwide patent disputes over its Eylea 2mg (aflibercept) biosimilar and setting 2026 launch dates across the UK, Canada, Japan, the European Economic Area and other markets, alongside an earlier U.S. license entry date. This settlement removes a key legal overhang and gives Alvotech and its partners clear worldwide rights to manufacture and supply the...
NYSE:HCI
NYSE:HCIInsurance

Assessing HCI Group (HCI) Valuation After Recent Share Price Weakness

HCI Group (HCI) has drawn investor attention after recent share price volatility, with the stock showing a 17% decline over the past month and a 22% decline over the past three months. See our latest analysis for HCI Group. Even after the recent 17% one month and 22% three month share price declines, HCI Group’s latest share price of $158.67 sits against a one year total shareholder return of 31.54% and a very large 3 year total shareholder return of more than 7x. This suggests recent...
NYSE:ORC
NYSE:ORCMortgage REITs

Orchid Island Capital (ORC) Q3 Revenue Surge Challenges Bearish Volatility Narratives

Orchid Island Capital (ORC) just posted its FY 2025 third quarter numbers, reporting total revenue of US$77.5 million and basic EPS of US$0.53. This sits alongside trailing twelve month revenue of US$80.2 million and EPS of US$0.57, which were delivered through a choppy set of quarterly results. The company has seen revenue move from US$21.6 million with EPS of US$0.24 in Q3 2024 to US$77.5 million and EPS of US$0.53 in Q3 2025, with interim quarters including both gains and losses that...
NYSE:ELAN
NYSE:ELANPharmaceuticals

A Look At Elanco Animal Health (ELAN) Valuation After Recent Share Price Swings

Elanco Animal Health (ELAN) is back on investors’ radar after recent share price swings, with the stock showing mixed short term performance and a stronger total return profile over the past year. See our latest analysis for Elanco Animal Health. Recent trading has cooled slightly, with a 1 day share price return of 0.50% and a 7 day share price return of 1.31%. However, the 30 day and 90 day share price returns of 6.41% and 8.71% sit alongside a 1 year total shareholder return of 100.17%,...
OB:SUBC
OB:SUBCEnergy Services

How Shell’s Kaikias Waterflood Contract Win At Subsea 7 (OB:SUBC) Has Changed Its Investment Story

Subsea 7 S.A. recently announced a sizeable contract award from Shell for the Kaikias Waterflood deepwater project in the US Gulf of Mexico, covering the transportation and installation of subsea umbilicals, a riser and a rigid flowline in water depths up to 1,650 metres, with offshore work scheduled for 2027. This award adds to Subsea 7’s future workload while reinforcing its role as a key offshore contractor for Shell’s deepwater developments. We will now examine how this new Shell...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Alliance Resource Warns Mountain View Mine Workers As Coal Demand Shifts

Alliance Resource Partners (NasdaqGS:ARLP) has issued WARN Act notices to all employees at its Mettiki subsidiary’s Mountain View Mine. The move follows reduced coal demand from a key customer and raises the possibility of a permanent closure of the mine. The decision affects hundreds of jobs and could have material implications for future coal sales volumes and asset values. For investors watching Alliance Resource Partners, the Mountain View Mine news lands as the units trade around...